Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 328

1.

Asymptomatic Pulmonary Artery Intimal Sarcoma with Chest Wall Metastasis as an Initial Manifestation: An Autopsy Case.

Kakimoto T, Sasaki M, Morinaga S, Nakayama R, Minematsu N.

Case Rep Med. 2018 May 27;2018:6153658. doi: 10.1155/2018/6153658. eCollection 2018.

2.

Histological Risk Factors to Predict Clinical Relapse in Ulcerative Colitis with Endoscopically Normal Mucosa.

Ozaki R, Kobayashi T, Okabayashi S, Nakano M, Morinaga S, Hara A, Ohbu M, Matsuoka K, Toyonaga T, Saito E, Hisamatsu T, Hibi T.

J Crohns Colitis. 2018 Jun 25. doi: 10.1093/ecco-jcc/jjy092. [Epub ahead of print]

PMID:
29939231
3.

Nonsmall Cell Lung Carcinoma with Giant Cell Features Expressing Programmed Death-Ligand 1: A Report of a Patient Successfully Treated with Pembrolizumab.

Nakayama S, Sasaki M, Morinaga S, Minematsu N.

Case Rep Oncol Med. 2018 Mar 15;2018:5863015. doi: 10.1155/2018/5863015. eCollection 2018.

4.

[Evaluation of Body Temperature during Pancreaticoduodenectomy for Pancreatic Cancer in Elderly Patients Aged over 75 Years Old].

Aoyama T, Hosono Y, Ikumi N, Ota Y, Ito M, Ishii F, Kishi H, Murakawa M, Atsumi Y, Kazama K, Rino Y, Masuda M, Morinaga S.

Gan To Kagaku Ryoho. 2018 Feb;45(2):282-284. Japanese.

PMID:
29483421
5.

Functional divergence of duplicate genes several million years after gene duplication in Arabidopsis.

Hanada K, Tezuka A, Nozawa M, Suzuki Y, Sugano S, Nagano AJ, Ito M, Morinaga SI.

DNA Res. 2018 Feb 21. doi: 10.1093/dnares/dsy005. [Epub ahead of print]

6.

Health-related quality of life of adjuvant chemotherapy with S-1 versus gemcitabine for resected pancreatic cancer: Results from a randomised phase III trial (JASPAC 01).

Hagiwara Y, Ohashi Y, Uesaka K, Boku N, Fukutomi A, Okamura Y, Konishi M, Matsumoto I, Kaneoka Y, Shimizu Y, Nakamori S, Sakamoto H, Morinaga S, Kainuma O, Imai K, Sata N, Hishinuma S, Ojima H, Yamaguchi R, Hirano S, Sudo T; JASPAC 01 Study Group.

Eur J Cancer. 2018 Apr;93:79-88. doi: 10.1016/j.ejca.2018.01.081. Epub 2018 Mar 20.

PMID:
29477795
7.

[Solitary Fibrous Tumor of the Kidney].

Ikeda M, Sakata Y, Tachibana T, Yamashita H, Takashima R, Hara A, Morinaga S, Irie A.

Hinyokika Kiyo. 2017 Nov;63(11):471-474. doi: 10.14989/ActaUrolJap_63_11_471. Japanese.

PMID:
29232798
8.

Steroid-refractory extensive enteritis complicated by ulcerative colitis successfully treated with adalimumab.

Okabayashi S, Kobayashi T, Sujino T, Ozaki R, Umeda S, Toyonaga T, Saito E, Nakano M, Tablante MC, Morinaga S, Hibi T.

Intest Res. 2017 Oct;15(4):535-539. doi: 10.5217/ir.2017.15.4.535. Epub 2017 Oct 23.

9.

[A Case of Surgical Resection of Hepatic Leiomyosarcoma].

Aoyama T, Kamiya M, Murakawa M, Atsumi Y, Kazama K, Yamamoto N, Sato T, Yukawa N, Yoshikawa T, Oshima T, Rino Y, Masuda M, Morinaga S.

Gan To Kagaku Ryoho. 2017 Oct;44(10):924-925. Japanese.

PMID:
29066697
10.

Switch to miriplatin for multinodular hepatocellular carcinoma unresponsive to transarterial chemoembolization with epirubicin: a prospective study.

Goda Y, Morimoto M, Irie K, Kobayashi S, Ueno M, Moriya S, Tezuka S, Ohkawa S, Morinaga S, Numata K, Tanaka K, Maeda S.

Jpn J Clin Oncol. 2017 Dec 1;47(12):1151-1156. doi: 10.1093/jjco/hyx131.

PMID:
28977459
11.

Clinical pharmacokinetics and pharmacodynamic target attainment of pazufloxacin in prostate tissue: Dosing considerations for prostatitis.

Nakamura K, Ikawa K, Nishikawa G, Kobayashi I, Narushima M, Muramatsu H, Morinaga S, Kajikawa K, Kato Y, Watanabe M, Zennami K, Kanao K, Morikawa N, Sumitomo M.

J Infect Chemother. 2017 Dec;23(12):809-813. doi: 10.1016/j.jiac.2017.08.005. Epub 2017 Oct 12.

PMID:
28923301
12.

Anesthetic management of a patient with chromosome 6p duplication: a case report.

Morinaga S, Tsukamoto M, Yokoyama T.

J Dent Anesth Pain Med. 2017 Jun;17(2):139-141. doi: 10.17245/jdapm.2017.17.2.139. Epub 2017 Jun 29.

13.

Clinical implications of dihydropyrimidine dehydrogenase expression in patients with pancreatic cancer who undergo curative resection with S-1 adjuvant chemotherapy.

Murakawa M, Aoyama T, Miyagi Y, Atsumi Y, Kazama K, Yamaoku K, Kanazawa A, Shiozawa M, Kobayashi S, Ueno M, Morimoto M, Yamamoto N, Oshima T, Yoshikawa T, Rino Y, Masuda M, Morinaga S.

Oncol Lett. 2017 Aug;14(2):1505-1511. doi: 10.3892/ol.2017.6295. Epub 2017 Jun 1.

14.

Predictive role of human equilibrative nucleoside transporter 1 in patients with pancreatic cancer treated by curative resection and gemcitabine-only adjuvant chemotherapy.

Aoyama T, Kazama K, Miyagi Y, Murakawa M, Yamaoku K, Atsumi Y, Shiozawa M, Ueno M, Morimoto M, Oshima T, Yukawa N, Yoshikawa T, Rino Y, Masuda M, Morinaga S.

Oncol Lett. 2017 Jul;14(1):599-606. doi: 10.3892/ol.2017.6220. Epub 2017 May 19.

15.

Clinicopathological significance and impact on outcomes of the gene expression levels of IGF-1, IGF-2 and IGF-1R, IGFBP-3 in patients with colorectal cancer: Overexpression of the IGFBP-3 gene is an effective predictor of outcomes in patients with colorectal cancer.

Yamamoto N, Oshima T, Yoshihara K, Aoyama T, Hayashi T, Yamada T, Sato T, Shiozawa M, Yoshikawa T, Morinaga S, Rino Y, Kunisaki C, Tanaka K, Akaike M, Imada T, Masuda M.

Oncol Lett. 2017 May;13(5):3958-3966. doi: 10.3892/ol.2017.5936. Epub 2017 Mar 28.

16.

Clinical implications of ribonucleotide reductase subunit M1 in patients with pancreatic cancer who undergo curative resection followed by adjuvant chemotherapy with gemcitabine.

Aoyama T, Miyagi Y, Murakawa M, Yamaoku K, Atsumi Y, Shiozawa M, Ueno M, Morimoto M, Oshima T, Yukawa N, Yoshikawa T, Rino Y, Masuda M, Morinaga S.

Oncol Lett. 2017 May;13(5):3423-3430. doi: 10.3892/ol.2017.5935. Epub 2017 Mar 28.

17.

Structural insights into the nucleotide base specificity of P2X receptors.

Kasuya G, Fujiwara Y, Tsukamoto H, Morinaga S, Ryu S, Touhara K, Ishitani R, Furutani Y, Hattori M, Nureki O.

Sci Rep. 2017 Mar 23;7:45208. doi: 10.1038/srep45208.

18.

Identification and characterization of the bombykal receptor in the hawkmoth Manduca sexta.

Wicher D, Morinaga S, Halty-deLeon L, Funk N, Hansson B, Touhara K, Stengl M.

J Exp Biol. 2017 May 15;220(Pt 10):1781-1786. doi: 10.1242/jeb.154260. Epub 2017 Mar 2.

19.

Clinical significance of human intestinal spirochetosis: a retrospective study.

Umeda S, Serizawa H, Kobayashi T, Toyonaga T, Saito E, Nakano M, Higuchi H, Tsunematsu S, Watanabe N, Hibi T, Morinaga S.

Nihon Shokakibyo Gakkai Zasshi. 2017;114(2):230-237. doi: 10.11405/nisshoshi.114.230. Japanese.

PMID:
28163288
20.

[A Case of Primary Liposarcoma Arising from the Duodenum].

Kazama K, Aoyama T, Murakawa M, Yamaoku K, Atsumi Y, Higuchi A, Shiozawa M, Kobayashi S, Ueno M, Morimoto M, Yamamoto N, Sato T, Yukawa N, Oshima T, Yoshikawa T, Rino Y, Masuda M, Morinaga S.

Gan To Kagaku Ryoho. 2016 Nov;43(12):2359-2361. Japanese.

PMID:
28133321
21.

[A Case of Primary Splenic Inflammatory Myofibroblastic Tumor].

Atsumi Y, Murakawa M, Yamaoku K, Aoyama T, Kanazawa A, Higuchi A, Shiozawa M, Kobayashi S, Ueno M, Morimoto M, Washimi K, Yokose T, Yamamoto N, Oshima T, Yukawa N, Yoshikawa T, Rino Y, Masuda M, Morinaga S.

Gan To Kagaku Ryoho. 2016 Nov;43(12):2268-2270. Japanese.

PMID:
28133291
22.

[Safety and Feasibility of Pancreatic Surgery for Pancreatic Cancer in Elderly Patients].

Aoyama T, Murakawa M, Kazama K, Kanazawa A, Satoyoshi T, Atsumi Y, Katayama Y, Yamaoku K, Kobayashi S, Ueno M, Morimoto M, Higuchi A, Shiozawa M, Yamamoto N, Oshima T, Yukawa N, Yoshikawa T, Rino Y, Masuda M, Morinaga S.

Gan To Kagaku Ryoho. 2016 Nov;43(12):1521-1522. Japanese.

PMID:
28133043
23.

[A Case of Pancreatic Cancer Associated with Autoimmune Pancreatitis].

Aoyama T, Murakawa M, Atsumi Y, Kazama K, Shiozawa M, Kobayashi S, Ueno M, Morimoto M, Washimi K, Yukawa N, Rino Y, Masuda M, Morinaga S.

Gan To Kagaku Ryoho. 2016 Oct;43(10):1289-1291. Japanese.

PMID:
27760963
24.

Effectiveness of alendronate for bone disorder after gastrectomy for gastric cancer.

Atsumi Y, Rino Y, Sato T, Cho H, Yoshikawa T, Yamamoto N, Oshima T, Yukawa N, Shiozawa M, Morinaga S, Masuda M.

Asian J Surg. 2017 Nov;40(6):470-474. doi: 10.1016/j.asjsur.2016.07.003. Epub 2016 Aug 18.

25.

Duodenal stenting followed by systemic chemotherapy for patients with pancreatic cancer and gastric outlet obstruction.

Kobayashi S, Ueno M, Kameda R, Moriya S, Irie K, Goda Y, Tezuka S, Yanagida N, Ohkawa S, Aoyama T, Morinaga S, Morimoto M.

Pancreatology. 2016 Nov - Dec;16(6):1085-1091. doi: 10.1016/j.pan.2016.07.007. Epub 2016 Jul 11.

PMID:
27424479
26.

An EP2 Agonist Facilitates NMDA-Induced Outward Currents and Inhibits Dendritic Beading through Activation of BK Channels in Mouse Cortical Neurons.

Hayashi Y, Morinaga S, Liu X, Zhang J, Wu Z, Yokoyama T, Nakanishi H.

Mediators Inflamm. 2016;2016:5079597. doi: 10.1155/2016/5079597. Epub 2016 May 19.

27.

Adjuvant chemotherapy of S-1 versus gemcitabine for resected pancreatic cancer: a phase 3, open-label, randomised, non-inferiority trial (JASPAC 01).

Uesaka K, Boku N, Fukutomi A, Okamura Y, Konishi M, Matsumoto I, Kaneoka Y, Shimizu Y, Nakamori S, Sakamoto H, Morinaga S, Kainuma O, Imai K, Sata N, Hishinuma S, Ojima H, Yamaguchi R, Hirano S, Sudo T, Ohashi Y; JASPAC 01 Study Group.

Lancet. 2016 Jul 16;388(10041):248-57. doi: 10.1016/S0140-6736(16)30583-9. Epub 2016 Jun 2.

PMID:
27265347
28.

BK channels in microglia are required for morphine-induced hyperalgesia.

Hayashi Y, Morinaga S, Zhang J, Satoh Y, Meredith AL, Nakata T, Wu Z, Kohsaka S, Inoue K, Nakanishi H.

Nat Commun. 2016 May 31;7:11697. doi: 10.1038/ncomms11697.

29.

From the laboratory to the field: assaying histone methylation at FLOWERING LOCUS C in naturally growing Arabidopsis halleri.

Nishio H, Buzas DM, Nagano AJ, Suzuki Y, Sugano S, Ito M, Morinaga S, Kudoh H.

Genes Genet Syst. 2016 Jul 20;91(1):15-26. doi: 10.1266/ggs.15-00071. Epub 2016 May 2.

30.

The Surgical Apgar Score Is an Independent Prognostic Factor in Patients with Pancreatic Cancer Undergoing Pancreatoduodenectomy Followed by Adjuvant Chemotherapy.

Aoyama T, Kazama K, Murakawa M, Atsumi Y, Shiozawa M, Kobayashi S, Ueno M, Morimoto M, Yukawa N, Oshima T, Yoshikawa T, Rino Y, Masuda M, Morinaga S.

Anticancer Res. 2016 May;36(5):2497-503.

PMID:
27127164
31.

Combining the Glasgow Prognostic Score and Serum Carbohydrate Antigen 19-9 Level Improves the Ability to Predict Early Recurrence in Resected Pancreatic Cancer Patients Receiving Adjuvant Gemcitabine.

Numata K, Morinaga S, Katayama Y, Sawazaki S, Numata M, Godai T, Higuchi A, Shiozawa M, Rino Y, Masuda M, Akaike M.

Anticancer Res. 2016 May;36(5):2467-74.

PMID:
27127159
32.

Ovarian Sertoli-Leydig cell tumor with heterologous elements containing an unusual type of alpha-fetoprotein-producing cells.

Ikota H, Kaneko K, Morinaga S, Takahashi S, Yokoo H.

Pathol Int. 2016 Jul;66(7):411-2. doi: 10.1111/pin.12413. Epub 2016 Apr 29. No abstract available.

PMID:
27126717
33.

[A Case of Glycogen-Rich Clear Cell Carcinoma of the Breast with Extensive Intraductal Components and Micrometastases to the Axillary Lymph Node].

Seki H, Sasaki K, Morinaga S, Asanuma F, Yanaihara H, Kaneda M, Suzuki K, Ishii Y, Kamiya N, Osaku M, Ikeda T.

Gan To Kagaku Ryoho. 2016 Feb;43(2):239-41. Japanese.

PMID:
27067690
34.

Low-grade cribriform cystadenocarcinoma arising from a minor salivary gland: a case report.

Kimura M, Mii S, Sugimoto S, Saida K, Morinaga S, Umemura M.

J Oral Sci. 2016;58(1):145-9. doi: 10.2334/josnusd.58.145.

35.

Locked Nucleic Acid In Situ Hybridization Analysis of MicroRNA-21 Predicts Clinical Outcome in Patients After Resection for Pancreatic Cancer Treated with Adjuvant Gemcitabine Monotherapy.

Morinaga S, Nakamura Y, Atsumi Y, Murakawa M, Yamaoku K, Aoyama T, Kobayashi S, Ueno M, Morimoto M, Yokose T, Miyagi Y.

Anticancer Res. 2016 Mar;36(3):1083-8.

PMID:
26977002
36.

[Safety and Feasibility of the Bioabsorbable Staple Line Reinforcement in Distal Pancreatic Resections].

Aoyama T, Murakawa M, Yamaoku K, Kanazawa A, Higuchi A, Shiozawa M, Morimoto M, Yamamoto N, Oshima T, Yukawa N, Yoshikawa T, Rino Y, Masuda M, Morinaga S.

Gan To Kagaku Ryoho. 2015 Nov;42(12):2349-50. Japanese.

PMID:
26805360
37.

[A Case of Undifferentiated Carcinoma of the Gallbladder].

Atsumi Y, Aoyama T, Murakawa M, Yamaoku K, Shiozawa M, Kobayashi S, Washimi K, Kawachi K, Yamamoto N, Oshima T, Yukawa N, Yoshikawa T, Rino Y, Masuda M, Morinaga S.

Gan To Kagaku Ryoho. 2015 Nov;42(12):1743-5. Japanese.

PMID:
26805158
38.

[The Safety and Feasibility of Conversion Surgery for Initially Unresectable Pancreatic Cancer].

Murakawa M, Aoyama T, Kazama K, Atsumi Y, Yamaoku K, Kanazawa A, Higuchi A, Yamamoto N, Oshima T, Yukawa N, Shiozawa M, Yoshikawa T, Rino Y, Masuda M, Morinaga S.

Gan To Kagaku Ryoho. 2015 Nov;42(12):1482-4. Japanese.

PMID:
26805070
39.

The short- and long-term outcomes of radical antegrade modular pancreatosplenectomy for adenocarcinoma of the body and tail of the pancreas.

Murakawa M, Aoyama T, Asari M, Katayama Y, Yamaoku K, Kanazawa A, Higuchi A, Shiozawa M, Kobayashi S, Ueno M, Morimoto M, Yamamoto N, Yoshikawa T, Rino Y, Masuda M, Morinaga S.

BMC Surg. 2015 Oct 30;15:120. doi: 10.1186/s12893-015-0107-0.

40.

Correction: A Genome Scan for Genes Underlying Microgeographic-Scale Local Adaptation in a Wild Arabidopsis Species.

Kubota S, Iwasaki T, Hanada K, Nagano AJ, Fujiyama A, Toyoda A, Sugano S, Suzuki Y, Hikosaka K, Ito M, Morinaga S.

PLoS Genet. 2015 Sep 22;11(9):e1005488. doi: 10.1371/journal.pgen.1005488. eCollection 2015 Sep. No abstract available.

41.

[Hepatocyte nuclear factor 1α-inactivated hepatocellular adenomatosis in a patient with maturity-onset diabetes of the young type 3: case report and literature review].

Hirata E, Shimizu S, Umeda S, Kobayashi T, Nakano M, Higuchi H, Serizawa H, Iwasaki N, Morinaga S, Tsunematsu S.

Nihon Shokakibyo Gakkai Zasshi. 2015;112(9):1696-704. doi: 10.11405/nisshoshi.112.1696. Review. Japanese.

PMID:
26346360
42.

Potential prognostic significance of a new proteomic profile in patients with advanced pancreatic adenocarcinoma.

Kobayashi S, Ueno M, Irie K, Goda Y, Aoyama T, Morinaga S, Ohkawa S, Morimoto M.

Pancreatology. 2015 Sep-Oct;15(5):525-530. doi: 10.1016/j.pan.2015.07.003. Epub 2015 Jul 29.

PMID:
26255025
43.

Glasgow Prognostic Score Predicts Clinical Outcomes in Patients with Pancreatic Cancer Undergoing Adjuvant Gemcitabine Monotherapy After Curative Surgery.

Morinaga S, Murakawa M, Katayama Y, Yamaoku K, Aoyama T, Kanazawa A, Higuchi A, Shiozawa M, Kobayashi S, Ueno M, Morimoto M.

Anticancer Res. 2015 Sep;35(9):4865-70.

PMID:
26254380
44.

Endoscopic snare papillectomy for a solitary Peutz-Jeghers-type polyp in the duodenum with ingrowth into the common bile duct: Case report.

Suzuki K, Higuchi H, Shimizu S, Nakano M, Serizawa H, Morinaga S.

World J Gastroenterol. 2015 Jul 14;21(26):8215-20. doi: 10.3748/wjg.v21.i26.8215. Review.

45.

A Genome Scan for Genes Underlying Microgeographic-Scale Local Adaptation in a Wild Arabidopsis Species.

Kubota S, Iwasaki T, Hanada K, Nagano AJ, Fujiyama A, Toyoda A, Sugano S, Suzuki Y, Hikosaka K, Ito M, Morinaga S.

PLoS Genet. 2015 Jul 14;11(7):e1005361. doi: 10.1371/journal.pgen.1005361. eCollection 2015 Jul. Erratum in: PLoS Genet. 2015 Sep;11(9):e1005488.

46.

A case of metastatic female adnexal tumor of probable Wolffian origin.

Deshimaru R, Fukunaga T, Sato T, Morinaga S, Takahashi M.

Gynecol Oncol Rep. 2014 Oct 1;10:22-4. doi: 10.1016/j.gore.2014.07.001. eCollection 2014 Dec.

47.

Establishment of patient-derived cancer xenografts in immunodeficient NOG mice.

Chijiwa T, Kawai K, Noguchi A, Sato H, Hayashi A, Cho H, Shiozawa M, Kishida T, Morinaga S, Yokose T, Katayama M, Takenaka N, Suemizu H, Yamada R, Nakamura Y, Ohtsu T, Takano Y, Imai K, Miyagi Y, Nakamura M.

Int J Oncol. 2015 Jul;47(1):61-70. doi: 10.3892/ijo.2015.2997. Epub 2015 May 11.

48.

Lymphatic invasion is an independent prognostic factor in pancreatic cancer patients undergoing curative resection followed by adjuvant chemotherapy with gemcitabine or S-1.

Aoyama T, Murakawa M, Katayama Y, Shiozawa M, Ueno M, Morimoto M, Yoshikawa T, Rino Y, Masuda M, Morinaga S.

Hepatogastroenterology. 2015 Mar-Apr;62(138):472-7.

PMID:
25916085
49.

Clinical implication of peritoneal cytology in the pancreatic cancer patients who underwent curative resection followed by adjuvant gemcitabine or S-1 chemotherapy.

Aoyama T, Katayama Y, Murakawa M, Shiozawa M, Morimoto M, Yamamoto N, Yoshikawa T, Rino Y, Masuda M, Morinaga S.

Hepatogastroenterology. 2015 Jan-Feb;62(137):200-6.

PMID:
25911897
50.

Impact of postoperative complications on survival and recurrence in pancreatic cancer.

Aoyama T, Murakawa M, Katayama Y, Yamaoku K, Kanazawa A, Higuchi A, Shiozawa M, Morimoto M, Yoshikawa T, Yamamoto N, Rino Y, Masuda M, Morinaga S.

Anticancer Res. 2015 Apr;35(4):2401-9.

PMID:
25862906

Supplemental Content

Loading ...
Support Center